how safe are glp 1 drugs GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 Medications: Is Ozempic the

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials

Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M) Diabetes Care

These trends are expected to have a material impact on a number of non-health industries, with some benefiting and others disadvantaged, although there is a lack of consensus on the scale and timing of the impact

Emerging Trends and Market Dynamics The GLP-1 market is poised for significant growth, with Novo Nordisk and Eli Lilly set to launch new injectables and oral formulations

Two large, randomized control trials investigating liraglutide and semaglutide have suggested worsening retinopathy as an adverse effect of GLP-1RA use

thetaiotaomicron regulates exercise activity by reducing the levels of GLP-1 through vagus nerve-dependent GLP-1 signaling pathway ( Clostridium butyricum ( Cb ) treatment reversed MPTP-induced intestinal microbiota dysregulation and decreased GLP-1, GPR41/43 and brain GLP-1 receptor levels in mice (Yoon et al., 2021